Skip to content
News
Alert
: Learn How the One Big Beautiful Bill Act makes America safe again.
News
Alert
: Learn How the One Big Beautiful Bill Act makes America safe again.
About
The Committee
The Chair
The Ranking Member
Membership
Subcommittees
Committee Rules
Clerkships
Committee Activity
Hearings
Oversight
Legislation
Committee Documents
Nominations
Executive Nominations
Judicial Nominations
Supreme Court
Confirmed Nominations
Latest News
Majority Press
Minority Press
Press Kit
Website Search Open
Submit Site Search Query
Website Search
Senator Facebook
Twitter
Instagram
Home Logo Link
Committee Activity
Hearings
Subcommittee on Intellectual Property
The State of Patent Eligibility in America: Part III
Type:
Subcommittee Hearing
Date:
Tuesday, June 11th, 2019
Time:
02:30pm
Location:
Dirksen Senate Office Building
226
Presiding:
Chairman Tillis
Open in New Window
Panel I
Mr.
Manny Schecter
Chief Patent Counsel
IBM
Armonk, NY
Schecter Responses to Questions for the Record
Ms.
Laurie Self
Senior Vice-President and Counsel, Government Affairs
Qualcomm
Washington, DC
Self Testimony
Self Responses to Questions for the Record
Mr.
Byron Holz
Senior Intellectual Property Rights Licensing Counsel
Nokia
Snellville, GA
Holz Testimony
Holz Responses to Questions for the Record
Ms.
Kim Chotkowski
Vice President, Head of Licensing Strategy and Operations
InterDigital
Washington, DC
Chotkowski Testimony
Mr.
Sean Reilly
Senior Vice President and Associate General Counsel
The Clearing House Payments Company
New York, NY
Reilly Testimony
Download Responses to Questions for the Record
Panel II
Ms.
Laurie Hill
Vice President, Intellectual Property
Genentech
San Francisco, CA
Hill Testimony
Hill Responses to Questions for the Record
Mr.
Sean George
Chief Executive Officer
Invitae
San Francisco, CA
George Testimony
George Responses to Questions for the Record
Mr.
Gonzalo Merino
Vice President and Chief Intellectual Property Counsel
Regeneron Pharmaceuticals
New York, NY
Merino Testimony
Merino Responses to Questions for the Record
Mr.
Peter O'Neill
Executive Director
Cleveland Clinic Innovations
Cleveland, OH
O'Neill Testimony
O'Neill Responses to Questions for the Record
Dr.
David Spetzler
President and Chief Scientific Officer
Caris Life Sciences
Irving, TX
Spetzler Testimony
Spetzler Responses to Questions for the Record
Panel III
Mr.
Michael Blankstein
Senior Vice President and Deputy General Counsel - Patents and Licensing
Scientific Games
Las Vegas, NV
Blankstein Testimony
Download Responses to Questions for the Record
Mr.
Corey Salsberg
Vice President, Global Head IP Affairs
Novartis
Washington, DC
Salsberg Testimony
Salsberg Responses to Questions for the Record
Mr.
Nicolas Dupont
CEO and Executive Chairman
Cyborg Inc.
New York, NY
Dupont Testimony
Download Responses to Questions for the Record
Mr.
Robert Deberadine
Chief Intellectual Property Counsel
Johnson & Johnson
New Brunswick, NJ
Deberardine Testimony
Deberardine Responses to Questions for the Record
Mr.
John D. Vandenberg
Partner
Klarquist Sparkman, LLP
Sherwood, OR
Vandenberg Testimony
Vandenberg Responses to Questions for the Record
About
The Committee
The Chair
The Ranking Member
Membership
Subcommittees
Committee Rules
Clerkships
Committee Activity
Hearings
Oversight
Legislation
Committee Documents
Nominations
Executive Nominations
Judicial Nominations
Supreme Court
Confirmed Nominations
Latest News
Majority Press
Minority Press
Press Kit
website-search
Site Search